Literature DB >> 17988079

Novel single-chain Fv' formats for the generation of immunoliposomes by site-directed coupling.

Sylvia K E Messerschmidt1, Anke Kolbe, Dafne Müller, Michael Knoll, Jürgen Pleiss, Roland E Kontermann.   

Abstract

Immunoliposomes generated by coupling of antibodies to the liposomal surface allow for an active targeting of entrapped compounds to diseased areas. Single-chain Fv fragments (scFv) represent the smallest part of an antibody containing the entire antigen-binding site. They can be coupled in a defined and site-directed manner through genetically engineered cysteine residues, for example, those added at the C-terminus. Here, we have performed a comparative analysis of various scFv' variants with cysteine residues present at the end of a C-terminal extension of varying length and composition (HC variants) or introduced in the linker sequence connecting the variable heavy and light chain domain (LC variants). Using a scFv fragment directed against fibroblast activation protein (FAP) as a model antibody, we could show that all variants can be employed for the generation of active immunoliposomes, although the presence of three additional cysteine residues in one scFv' molecule resulted in decreased binding of immunoliposomes compared to that of immunoliposomes generated with scFv' molecules containing only one additional cysteine residue. In order to further improve the scFv' format by reducing the number of additional amino acid residues, we also generated molecules with the hexahistidyl-tag incorporated into the linker sequence together with a cysteine residue either at position 1 or 3 of the linker sequence (LCH variants). These newly designed scFv' molecules may be particularly suitable for the generation of immunoliposomes and other antibody conjugates, limiting the number of additional residues in these antibody molecules to a minimum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988079     DOI: 10.1021/bc700349k

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  9 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Use of single chain antibody derivatives for targeted drug delivery.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Masoumeh Khalili; Hossein Zarei Jaliani; Vahid Zarei; Vahid Erfani-Moghadam
Journal:  Mol Med       Date:  2016-04-22       Impact factor: 6.354

3.  Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.

Authors:  Colin F Greineder; Carlos H Villa; Landis R Walsh; Raisa Y Kiseleva; Elizabeth D Hood; Makan Khoshnejad; Robert Warden-Rothman; Andrew Tsourkas; Vladimir R Muzykantov
Journal:  Bioconjug Chem       Date:  2017-12-29       Impact factor: 4.774

4.  Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic Avian Influenza A (H5N1) virus infection.

Authors:  Kannika Khantasup; Phikulthong Kopermsub; Kridsada Chaichoun; Tararaj Dharakul
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

5.  Bioinformatics-led design of single-chain antibody molecules targeting DNA sequences for retinoblastoma.

Authors:  Guo-Gang Shang; Jian-Hua Zhang; Yong-Gang Lü; Jun Yun
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

6.  Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2.

Authors:  Shannon J Sirk; Tove Olafsen; Bhaswati Barat; Karl B Bauer; Anna M Wu
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

7.  Dataset on FAP-induced emergence of spontaneous metastases and on the preparation of activatable FAP-targeting immunoliposomes to detect the metastases.

Authors:  Felista L Tansi; Ronny Rüger; Claudia Böhm; Roland E Kontermann; Ulf K Teichgraeber; Alfred Fahr; Ingrid Hilger
Journal:  Data Brief       Date:  2016-09-03

8.  Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.

Authors:  Mesha Saeed; Mandy van Brakel; Sara Zalba; Erik Schooten; Joost A P Rens; Gerben A Koning; Reno Debets; Timo L M Ten Hagen
Journal:  Int J Nanomedicine       Date:  2016-03-08

9.  Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography.

Authors:  Darpan N Pandya; Akesh Sinha; Hong Yuan; Lysette Mutkus; Kristina Stumpf; Frank C Marini; Thaddeus J Wadas
Journal:  Molecules       Date:  2020-08-12       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.